FindDrugs.org

Ro Premature Ejaculation Review

Premature Ejaculation · Reviewed Sep 14, 2026

6.51/10
Ro operator trust7.34/10See the full Ro brand review
Insurance-friendlyNo commitmentCash-pay

Our verdict

Ro treats premature ejaculation primarily with off-label sertraline (an SSRI), with sildenafil when ED co-occurs and OTC Roman Swipes as an adjunct. The Black Box Warning on sertraline is surfaced, but pricing is entirely gated behind the free consultation.

Price

See site

Visit Ro

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Key takeaways

  • Off-label sertraline is the Rx anchor
  • Black Box Warning disclosed
  • No pricing shown before the consultation

What is Ro Premature Ejaculation?

Ro's premature-ejaculation program treats PE with off-label sertraline (an SSRI) prescribed after an online visit with a licensed provider, adding sildenafil when ED co-occurs and OTC Roman Swipes as an adjunct.

Treatment options

Prices as of Sep 14, 2026 — verify current on the brand's site.

Methodology scorecard

Scored on Sep 14, 2026 under methodology v6

6.51/10

Coverage: Checked against 6 recorded withdrawals. Marking matches the wording each withdrawal was recorded in, so the same claim stated differently is not marked.

One factor could not be established: Legitimacy & Accreditation

We could not establish this from a third-party record. What we searched: accreditation and licensing bodies — LegitScript, NABP including its .pharmacy verification, and URAC — state licensing registries, and the provider’s own corporate disclosures. On LegitScript we read the provider’s own website and never LegitScript’s register: their terms do not permit automated queries to it, so a LegitScript-issued seal found on a provider’s pages establishes that the seal was displayed there on that date, and not that a certification is current. No register, federal or otherwise, answers whether an operation is licensed in every state it ships to; of the six government hosts we read on 2026-08-25, three do not permit us. This is a statement about what we were able to verify, never a finding that the provider lacks accreditation. Where a provider states its own licensure or displays its own seal, that is recorded as the provider’s own claim and lifts no subscore by itself.

Pricing & cancellation

Visit Ro

All-in price

Cost structure
Month-to-month membership with optional prepaid annual plan.
Insurance vs. cash
Cash-pay
Deal structure
Cancellation
Cancel anytime to stop future renewals; membership fee non-refundable once billed for the current cycle.
Forced subscription
Not required

Pros & cons

Pros

  • Genuine clinician review with real prescriber oversight
  • Large, well-funded, high-momentum operator
  • Broad treatment catalog under one account
  • Discreet, free shipping

Cons

  • Membership billed separately from medication cost
  • Pricing frequently gated behind the intake quiz
  • Compounding pharmacies not named in any category
  • Heavy promotion of non-FDA-approved compounded formulations

Safety

Talk to a licensed clinician

Sertraline is an SSRI and carries a Black Box Warning for suicidal thoughts in some populations; off-label use for PE is disclosed by Ro. Benzocaine wipes can cause local numbness or irritation.

The bottom line

A legitimate PE option anchored on an off-label SSRI, with the systemic risks disclosed. Pricing transparency is weak. Newly reviewed — proposed pending approval.

Visit Ro

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

See how Ro ranks among PE providers

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 14, 2026Methodologymethodology v66.526.51

    We changed how this score is calculated, and Premature Ejaculation score moved from 6.52 to 6.51. 1 of the factors behind it moved. How we score.

    1 factor withdrawn — assessed coverage fell 10 → 9. Part of any score movement here reflects evidence we retracted, not a change in the brand.

  2. Aug 23, 2026Methodologymethodology v36.926.52

    We changed how this score is calculated, and Premature Ejaculation score moved from 6.92 to 6.52. 2 of the factors behind it moved. How we score.

    2 factors withdrawn — assessed coverage fell 12 → 10. Part of any score movement here reflects evidence we retracted, not a change in the brand.

Work at Ro?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Scored on 9 of 11 factors · 4 sources cited

Brand site

Reviews

What we couldn't verify

  • Fulfilling pharmacy and 503A/503B compounding pharmacy are not identified in any record we could retrieve.
  • Privacy/security posture rests on standard HIPAA-covered-telehealth assumptions; no independent audit trail was retrievable.
  • Individual prescribing clinician identities were not found in any record we could retrieve.
  • Withdrawn — Ro is LegitScript-certified. WITHDRAWN. legitscript.com/websites/ro.co/ returns HTTP 200 but serves a reCAPTCHA form shell with no certification status and no mention of ro.co (retrieved 2026-08-13); api.legitscript.com returns 403, seal-ID routes 404, the sitemap is empty, and ro.co's own badge is an unlinked image. The prior citation was the legitscript.com HOMEPAGE, which states nothing about Ro. Retrieval-failed, not disproved — the same test fridays failed with a 403.
  • Withdrawn — Ro funding/revenue figures (raised, valuation, revenue, projections). WITHDRAWN. Sourced only to sacra.com, a market-data aggregator that neither originates nor audits the figures. Ro is private; no filing or audited record is retrievable.
  • Withdrawn — Ro is a "preferred distribution partner" of Novo Nordisk and Eli Lilly. WITHDRAWN. Cited to press/affiliate only. Not re-pointable: novocare.com (200) names Ro on no fetchable page and lillydirect.lilly.com returns HTTP 403 (retrieval-failed). Ro's own claim to source through those channels is retained as company-attested.
  • Withdrawn — Ro surfaces contraindication warnings during intake. WITHDRAWN. A safety-behaviour claim resting on the company's own page; no label or registry record can establish what a telehealth intake surfaces.
  • Withdrawn — Ro operates provider-managed dose titration with starter-dose offerings and ongoing check-ins. WITHDRAWN and the factor EXCLUDED. A dosing claim requires a label or registry record; none describes a telehealth provider's titration practice.
  • Withdrawn — Ro "discloses membership terms, contraindications, and expected outcomes with cited studies". WITHDRAWN. A favourable disclosure-quality claim resting solely on Ro's own page; a label records what the contraindications are, not that Ro surfaces them, so it is not re-pointable (punch list § G9).
Last reviewed Sep 14, 2026 · methodology v6View the ledger

Top pick

Ro 6.51/10